Intuitive Surgical (ISRG) Projected to Release Quarterly Earnings on Thursday

Intuitive Surgical (NASDAQ:ISRG) is expected to post its Q2 2026 results after the market closes on Thursday, July 16th. Analysts expect the company to announce earnings of $2.48 per share and revenue of $2.8249 billion for the quarter. Investors can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, July 16, 2026 at 4:30 PM ET.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.81 EPS. On average, analysts expect Intuitive Surgical to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Intuitive Surgical Stock Down 2.9%

Intuitive Surgical stock opened at $415.10 on Thursday. Intuitive Surgical has a 52-week low of $396.68 and a 52-week high of $603.88. The firm has a market cap of $147.01 billion, a PE ratio of 50.32, a price-to-earnings-growth ratio of 3.48 and a beta of 1.46. The company’s 50 day moving average is $424.14 and its two-hundred day moving average is $476.26.

Analyst Ratings Changes

ISRG has been the topic of a number of recent research reports. Bank of America cut their price objective on Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. HSBC lowered their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Finally, Mizuho set a $525.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Twenty equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $569.20.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. The trade was a 49.79% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 7,169 shares of company stock valued at $3,059,135. Insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the business. Brighton Jones LLC lifted its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC boosted its holdings in Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares in the last quarter. Schnieders Capital Management LLC. increased its stake in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after purchasing an additional 268 shares during the last quarter. Colonial Trust Advisors increased its stake in Intuitive Surgical by 40.8% in the fourth quarter. Colonial Trust Advisors now owns 221 shares of the medical equipment provider’s stock valued at $125,000 after purchasing an additional 64 shares during the last quarter. Finally, Meeder Asset Management Inc. increased its stake in Intuitive Surgical by 153.2% in the fourth quarter. Meeder Asset Management Inc. now owns 195 shares of the medical equipment provider’s stock valued at $110,000 after purchasing an additional 118 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.